Condition

Bloodstream Infection clinical trials and research

• 7Clinical trials
• 2New in 30 days
• 16Countries

Newest Bloodstream Infection clinical trials

All recruiting trials (7)

• Oral switch for bloodstream infections in immunocompromised children

  This trial tests whether switching from IV to oral antibiotics is just as safe as continuing IV therapy for children with bloodstream infections who are immunocompromised or have a central venous catheter.

  Recruiting at 4 sites Phase 4 Copenhagen University Hospital, Rigshospitalet · Aalborg and 3 other locations · NCT07923266

• Middle East study of bloodstream infections in blood cancer patients and HSCT recipients

  This is an observational study to see how bloodstream infections affect adults with blood cancers or after stem cell transplants across several Middle East countries.

  Recruiting at 9 sites Hamad Medical Corporation · Amman and 8 other locations · NCT07900542

• Oral switch for kids with bloodstream infections after starting IV therapy

  This trial will test whether switching from IV to oral antibiotics early is not worse than continuing IV treatment for previously healthy children and teens with uncomplicated bloodstream infections.

  Recruiting at 18 sites Phase 4 Copenhagen University Hospital, Rigshospitalet · Aabenraa and 17 other locations · NCT07791914

• Sulbactam-Durlobactam for CRAB infections in real-world care

  This real-world study tests whether sulbactam-durlobactam works and is safe for adults with carbapenem-resistant Acinetobacter baumannii infections, compared with other anti-CRAB treatments.

  Recruiting Sichuan Provincial People's Hospital · Chengdu, Sichuan · NCT07601711

• Fast antibiotic sensitivity tests to guide treatment for bloodstream infections

  This tests whether rapid antibiotic susceptibility tests can help doctors pick the right antibiotics sooner for adults with positive blood cultures and improve recovery and antibiotic use.

  Recruiting Istituto Clinico Humanitas · Rozzano, Milan · NCT07491419

• Personalized antibiotic duration for high-risk febrile neutropenia with Gram-negative bloodstream infection

  This trial tests whether stopping antibiotics after a patient with a blood cancer and febrile neutropenia has been clinically stable for 72 hours is as safe and lets them spend more days off anti–Gram-negative antibiotics than the usual at least 10-day approach.

  Recruiting Humanitas University · Rozzano, Milan · NCT07372131

• Optimising treatment for severe Gram-negative infections

  This tests different antibiotic combinations to see if they improve 28-day survival for people with severe multidrug-resistant Gram-negative bloodstream or lower-respiratory infections.

  Recruiting Phase 4 National University of Singapore · Brisbane, Queensland and 40 other locations · NCT07004049

Related topics

Quick answers

How many Bloodstream Infection clinical trials are recruiting right now?

7, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in China (2 trials), Qatar (2 trials), Saudi Arabia (2 trials), United Arab Emirates (2 trials), Denmark (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →